George Hruby

68Ga-PSMA PET/CT-avid Tumour Volume: A Potential Prognostic Biomarker in Metastatic Hormone Sensitive Prostate Cancer

Greta Beale, Alexander Yuile, Wai-Hoong Chan, Joseph Chan et autres

Background Prostate-specific membrane antigen (PSMA) PET/CT provides sensitive whole-body assessment in prostate cancer, yet the prognostic role of total tumour volume (TTV) is not fully defined in metastatic hormone-sensitive disease and needs further exploration. Methods We retrospectively reviewed patients with de novo …

au (code pays fourni par la source)

Local Salvage Therapy Alone for Local Recurrence of Prostate Cancer After Radiotherapy: A Systematic Review and Meta-Analysis

Marcin Miszczyk, Federico Mastroleo, Anna Kujawska, Adam Gurwin et autres

Importance Standard-of-care management of radiorecurrent prostate cancer (PCa) involves systemic therapy; however, some patients seek to avoid the adverse events (AEs) that are associated with androgen-deprivation therapy (ADT). Objective To determine outcomes of local therapy without systemic therapy for radiorecurrent PCa. Data …

PSA persistence in the PSMA PET era: reassessing a risk factor after radical prostatectomy

Sophia Scharl, Reinhard Thamm, Constantinos Zamboglou, Iosif Strouthos et autres

BACKGROUND AND PURPOSE: The association of prostate-specific antigen (PSA) persistence after radical prostatectomy (RP) with inferior prognosis was demonstrated in a systematic review. However, all patients in the included studies lacked a prostate-specific membrane antigen Positron-Emissions-Tomography (PSMA-PET) before salvage radiotherapy (SRT). Since …

de, it, ch, au (code pays fourni par la source)

PSA persistence in the PSMA PET era: reassessing a risk factor after radical prostatectomy.

Sophia Scharl, Reinhard Thamm, Constantinos Zamboglou, Iosif Strouthos et autres

Background And Purpose The association of prostate-specific antigen (PSA) persistence after radical prostatectomy (RP) with inferior prognosis was demonstrated in a systematic review. However, all patients in the included studies lacked a prostate-specific membrane antigen Positron-Emissions-Tomography (PSMA-PET) before salvage radiotherapy (SRT). Since …

at, us (code pays fourni par la source)

Data-driven determination and validation of an optimised mid-treatment imaging interval for prostate stereotactic body radiotherapy using real-time intrafraction image records

Alannah Kejda, Mario Perez, Maegan Stewart, George Hruby et autres

au (code pays fourni par la source)

1739P Pembrolizumab with chemoradiotherapy as treatment for muscle invasive bladder cancer: Analysis of safety and efficacy of the PCR-MIB phase II clinical trial (ANZUP 1502)

A.J. Weickhardt, F. Foroudi, J. Xie, K. Kanojia et autres

au (code pays fourni par la source)